1、 MAGNUSSON M, LEWIS G D, ERICSON U, et al. A diabetes -predictive amino acid score and future cardiovascular disease[J]. Eur Heart J, 2013, 34(26): 1982-1989. MAGNUSSON M, LEWIS G D, ERICSON U, et al. A diabetes -predictive amino acid score and future cardiovascular disease[J]. Eur Heart J, 2013, 34(26): 1982-1989.
2、 NAGATA C, WADA K, TSUJI M, et al. Plasma amino acid profiles are associated with biomarkers of breast cancer risk in premenopausal Japanese women[J]. Cancer Causes Control, 2014, 25(2): 143-149. NAGATA C, WADA K, TSUJI M, et al. Plasma amino acid profiles are associated with biomarkers of breast cancer risk in premenopausal Japanese women[J]. Cancer Causes Control, 2014, 25(2): 143-149.
3、 YUAN Y S, ZHOU X J, TONG Q, et al. Change in plasma levels of amino acid neurotransmitters and its correlation with clinical heterogeneity in early Parkinson＇s disease patients[J]. CNS Neurosci Ther, 2013, 19(11): 889-896. YUAN Y S, ZHOU X J, TONG Q, et al. Change in plasma levels of amino acid neurotransmitters and its correlation with clinical heterogeneity in early Parkinson＇s disease patients[J]. CNS Neurosci Ther, 2013, 19(11): 889-896.
4、 段满乐, 伦立民. 缺血性脑血管疾病患者血浆氨基酸递质的测定及其意义[J]. 中华检验医学杂志, 2005, 28(12): 1256-1257. 段满乐, 伦立民. 缺血性脑血管疾病患者血浆氨基酸递质的测定及其意义[J]. 中华检验医学杂志, 2005, 28(12): 1256-1257.
5、 LEICHTLE A B, NUOFFER J M, CEGLAREK U, et al. Serum amino acid profiles and their alterations in colorectal cancer[J]. Metabolomics, 2012, 8(4):643-653. LEICHTLE A B, NUOFFER J M, CEGLAREK U, et al. Serum amino acid profiles and their alterations in colorectal cancer[J]. Metabolomics, 2012, 8(4):643-653.
6、 ALADDIN M, SAPNA G, HUDES G R, et al.Serum amino acid levels as a biomarker for renal cell carcinoma[J]. J Urol, 2011, 86(4):1206-1212. ALADDIN M, SAPNA G, HUDES G R, et al.Serum amino acid levels as a biomarker for renal cell carcinoma[J]. J Urol, 2011, 86(4):1206-1212.
7、 OGLESBEE D, SANDERS K A, LACEY J M, et al, Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD)[J]. Clin Chem, 2008, 54(3): 542-549. OGLESBEE D, SANDERS K A, LACEY J M, et al, Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD)[J]. Clin Chem, 2008, 54(3): 542-549.
8、 宋彦强, 夏黎黎, 李玮, 等. 血液中氨基酸检测方法研究进展[J]. 检验医学与临床, 2013, 10(24): 3361-3362. 宋彦强, 夏黎黎, 李玮, 等. 血液中氨基酸检测方法研究进展[J]. 检验医学与临床, 2013, 10(24): 3361-3362.
9、 冯雷, 陈章玉, 王保兴, 等. 柱前衍生化反相高效液相色谱法测定烟草中的游离氨基酸[J]. 云南大学学报: 自然科学版, 2003, 25(S1): 241-245. 冯雷, 陈章玉, 王保兴, 等. 柱前衍生化反相高效液相色谱法测定烟草中的游离氨基酸[J]. 云南大学学报: 自然科学版, 2003, 25(S1): 241-245.
10、 罗朵生, 李坤平, 朴胜华, 等. 高脂血症大鼠造模过程中血液代谢组学研究[J]. 中药新药与临床药理, 2016, 27(1): 70-74. 罗朵生, 李坤平, 朴胜华, 等. 高脂血症大鼠造模过程中血液代谢组学研究[J]. 中药新药与临床药理, 2016, 27(1): 70-74.
11、 苗华. 基于代谢组学技术研究泽泻对高脂血症大鼠防治的生物化学作用机制[J], 西北大学学报(自然科学版), 2016, 46(3): 397-402. 苗华. 基于代谢组学技术研究泽泻对高脂血症大鼠防治的生物化学作用机制[J], 西北大学学报(自然科学版), 2016, 46(3): 397-402.
12、 王远红, 徐家敏, 耿美玉, 等. 海洋硫酸多糖916对实验性高脂血症大鼠血浆中含硫氨基酸的影响[J]. 中国海洋药物, 2000(4): 23-24. 王远红, 徐家敏, 耿美玉, 等. 海洋硫酸多糖916对实验性高脂血症大鼠血浆中含硫氨基酸的影响[J]. 中国海洋药物, 2000(4): 23-24.
13、 刘冲. 高脂血症的证型特点研究[D]. 福州: 福建中医药大学, 2016. 刘冲. 高脂血症的证型特点研究[D]. 福州: 福建中医药大学, 2016.
